FIXX - Yandex Bilibili Mobile TeleSystems among premarket losers' pack

February, 22 2022 08:20 AM Homology Medicines Inc.

Homology Medicines (NASDAQ:FIXX) -25% on FDA clinical hold for phenylketonuria trial. Karyopharm Therapeutics (NASDAQ:KPTI) -23% as medical chief steps down. Inspirato (NASDAQ:ISPO) -17%. QIWI (NASDAQ:QIWI) -14%. Yandex (NASDAQ:YNDX) -13%. Energy Vault (NYSE:NRGV) -12%. Aridis Pharmaceuticals (NASDAQ:ARDS) -12%. Ozon Holdings (NASDAQ:OZON) -11%. Fast Radius (NASDAQ:FSRD) -11%. Anghami (NASDAQ:ANGH) -11%. Mobile TeleSystems (NYSE:MBT) -10%. Creative Medical Technology (NASDAQ:CELZ) -9%. Maris-Tech (NASDAQ:MTEK) -9%. Tempur Sealy International (NYSE:TPX) -9% on Q4 earnings release. Vinco Ventures (NASDAQ:BBIG) -8%. Theratechnologies (NASDAQ:THTX) -8%. Marin Software (NASDAQ:MRIN) -8%. BIMI International Medical (NASDAQ:BIMI) -8%. Bilibili (NASDAQ:BILI) -7%. Adagio Therapeutics (NASDAQ:ADGI) -7% on announcing ADG20 development plans and pipeline updates. Quanergy Systems (NYSE:QNGY) -7%. Sphere 3D (NASDAQ:ANY) -7%. Tritium DCFC (NASDAQ:DCFC) -7%. Cyngn (NASDAQ:CYN) -7%. Sunshine Biopharma (NASDAQ:SBFM) -7%. Ebang International (NASDAQ:EBON) -7%. Canaan (NASDAQ:CAN) -7%.

For further details see:

Yandex, Bilibili, Mobile TeleSystems among premarket losers' pack

Company Name:	Homology Medicines Inc.
Stock Symbol:	FIXX
Market:	NASDAQ
Website:	homologymedicines.com

Twitter